Press Releases:
November 20, 2003- Mpex Pharmaceuticals Signs Agreement with Mixture Sciences, Inc. Mixture to provide diverse collection of peptide and peptide-derived small molecule compounds to support the discovery of new antibacterial agents. more
December 16, 2002- Alliance Pharmaceutical Corp. and Mixture Sciences, Inc. Announce License Agreement. more
May 13, 2002 - Mixture Sciences, Inc. announces the renewal of a CRADA with the Neuroimmunology Branch, NINDS, NIH. more
April 16, 2002 - Mixture Sciences, Inc. co-authors recent article in Cancer Research the integration of combinatorial chemistry and bioinformatics for the development of tumor vaccines. more
Feb. 14, 2002 - Mixture Sciences, Inc. of San Diego, California, entered a research collaboration with HeptaHelix Ltd. of Lund, Sweden, to use Mixture Sciences mixture-based combinatorial libraries to identify ligands for HeptaHelix collection of G-protein coupled receptors using their sensitive reporter analysis, a kind of biosensor system. Mixture Sciences will provide a variety of mutually selected mixture-based combinatorial libraries. Mixture Sciences and HeptaHelix will use these libraries to identify ligands for a variety of mutually selected cell-based reporter-gene systems including G-protein coupled and orphan receptors. more
Sept.
30, 2001 - Mixture Sciences, Inc. (MSI), a privately
held biotechnology company that specializes in biomedical research in
San Diego, has been awarded a $600,000 Phase I SBIR by the National Institutes
of Health. MSI will use its proprietary technology involving very large
combinatorial peptide libraries to identify and optimize peptide mimics
of HIV-1 epitopes for use in the design of prophylactic vaccines for the
treatment of HIV infections. These studies are conducted in collaboration
with clinical investigators at the Karmanos Cancer Institute in Detroit,
Michigan. more
Sept. 7, 2001 - RTA Awards $726,525 To Promising High-Tech Start-Ups in San Diego, Including Mixture Sciences, Inc. more
June
28, 2001 - NeoGene Names Six Leading Genomics Experts
To New Scientific Advisory Board, Including Dr. Richard A. Houghten of
Mixture Sciences, Inc. more
Jan. 1, 2001 - Mixture Sciences, Inc. (MSI) is awarded funding from the Michigan Economic Development Corporation for the Michigan Life Sciences Corridor initiative through Wayne State University. The $616,000 award will fund the project titled "Mimic Peptides of Human T cell Epitopes as HIV Vaccines." This collaborative project between MSI and June Kan-Mitchell of the Barbara Ann Karmanos Cancer Institute aims to develop effective human immunodeficiency virus (HIV) vaccines that will have major sociological and commercial consequences.
Nov. 29, 1999 - New Tool Provides Major Advances for Understanding Chronic Lyme Disease and Other Illnesses. more
